Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series

BACKGROUND: Sacral neuromodulation is well established in the treatment of refractory, non-neurogenic lower urinary tract dysfunction, but its efficacy and safety in patients with lower urinary tract dysfunction of neurological origin is unclear. Only few case series have been reported for multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Engeler, Daniel S., Meyer, Daniel, Abt, Dominik, Müller, Stefanie, Schmid, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619407/
https://www.ncbi.nlm.nih.gov/pubmed/26498275
http://dx.doi.org/10.1186/s12894-015-0102-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619407/
https://www.ncbi.nlm.nih.gov/pubmed/26498275
http://dx.doi.org/10.1186/s12894-015-0102-x

Ejemplares similares